Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of co-administration of tetravalent dengue vaccine candidate and hepatitis A vaccine in healthy adults
2017-001071-23Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2017
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of dengue tetravalent vaccine, live, attenuated, Hepatitis A virus vaccine in dengue fever, hepatitis A (HAV), sponsored by Takeda. Started Nov 2017; status: completed.
02
Drugs
dengue tetravalent vaccine, live, attenuatedHepatitis A virus vaccine
03
Conditions
dengue feverhepatitis A (HAV)
Beyond the preview
Go deeper on 2017-001071-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001071-23.